CN106138832A - 一种海豹油应用于心律不齐、肝气不通的保健饼干 - Google Patents
一种海豹油应用于心律不齐、肝气不通的保健饼干 Download PDFInfo
- Publication number
- CN106138832A CN106138832A CN201610691589.3A CN201610691589A CN106138832A CN 106138832 A CN106138832 A CN 106138832A CN 201610691589 A CN201610691589 A CN 201610691589A CN 106138832 A CN106138832 A CN 106138832A
- Authority
- CN
- China
- Prior art keywords
- parts
- seal oil
- health
- cookies
- arrhythmia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010003119 arrhythmia Diseases 0.000 title claims abstract description 23
- 230000006793 arrhythmia Effects 0.000 title claims abstract description 23
- 206010022998 Irritability Diseases 0.000 title claims abstract description 20
- 235000015895 biscuits Nutrition 0.000 title claims abstract description 19
- 210000000582 semen Anatomy 0.000 claims abstract description 52
- 240000006394 Sorghum bicolor Species 0.000 claims abstract description 18
- 235000007230 Sorghum bicolor Nutrition 0.000 claims abstract description 18
- 235000013312 flour Nutrition 0.000 claims abstract description 15
- 108010052008 colla corii asini Proteins 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims description 26
- 235000014510 cooky Nutrition 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000004067 bulking agent Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 241001148495 Cibotium barometz Species 0.000 claims description 3
- 108010068370 Glutens Proteins 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 230000006378 damage Effects 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 235000019640 taste Nutrition 0.000 claims description 3
- 230000036541 health Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 6
- 208000029078 coronary artery disease Diseases 0.000 abstract description 5
- 208000031229 Cardiomyopathies Diseases 0.000 abstract description 3
- 208000009525 Myocarditis Diseases 0.000 abstract description 3
- 239000003792 electrolyte Substances 0.000 abstract description 3
- 230000000302 ischemic effect Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 208000004124 rheumatic heart disease Diseases 0.000 abstract description 3
- 208000002330 Congenital Heart Defects Diseases 0.000 abstract description 2
- 208000028831 congenital heart disease Diseases 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 28
- 235000019198 oils Nutrition 0.000 description 28
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 235000012907 honey Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 230000001256 tonic effect Effects 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 229940112824 paste Drugs 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229940031439 squalene Drugs 0.000 description 4
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000758789 Juglans Species 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 235000015505 Sorghum bicolor subsp. bicolor Nutrition 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 208000026758 coronary atherosclerosis Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- GJRJTYFSORWKBE-UHFFFAOYSA-N Aspidinol Chemical compound CCCC(=O)C1=C(O)C=C(OC)C(C)=C1O GJRJTYFSORWKBE-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 241000195958 Dicksoniaceae Species 0.000 description 1
- 241000085534 Dicoria Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 235000013757 Juglans Nutrition 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000028872 Progressive muscular dystrophy Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 235000014058 juice drink Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 235000021290 n-3 DPA Nutrition 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940052228 zinc oxide paste Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/34—Animal material
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Insects & Arthropods (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Animal Husbandry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种海豹油应用于心律不齐、肝气不通的保健饼干,其特征在于,它是由下述重量份的原料配制而成的:海豹油2~5份、大枣2~5份、黄芩2~5份、核桃仁2~5份、茴香1~3份、金毛狗脊2~6份、菟丝子2~5份、阿胶2~6份、蜂蜜5~10份、高粱面50~100份。本发明制得的保健饼干,可以针对人体新陈代谢异常预防保健,达到体内电解质平衡,肝气不顺的症状,缺血性心脏病(冠状动脉疾病),风湿性心脏病,心肌炎,心肌病变,及先天性心脏病等导致心律不齐也有一定的缓解改善。
Description
技术领域
本发明涉及饼干食品,尤其是提供一种海豹油应用于心律不齐、肝气不通的保健饼干。
背景技术
“心律不齐”指的是心跳或快或慢,超过了一般范围。心脏自律性异常或传导障碍引起的心动过速、心动过缓或心律不齐;精神紧张、大量吸烟、饮酒、喝浓茶或咖啡、过度疲劳、严重失眠等常为心律失常的诱发因素;心律失常特别多见于心脏病患者,也常发生在麻醉、手术中或手术后。如果肝气不舒,人的周身气血运行便会紊乱,出现高血压、消化系统紊乱等疾病,妇女还会出现月经不调的症状。
现在人们养生保健意识越来越强了,保健型的食品越来越多,市面上被人们追捧的供不应求,为了丰富保健食品品种律不齐、肝气不通的保健饼干具有一定市场推广价值。
发明内容
本发明的目的在于针对人体新陈代谢异常预防保健,达到体内电解质平衡,肝气不顺的症状,缺血性心脏病(冠状动脉疾病),风湿性心脏病,心肌炎,心肌病变,及先天性心脏病等导致心律不齐也有一定的缓解改善的一种海豹油应用于心律不齐、肝气不通的保健饼干,来解决上述背景技术所提出的问题。
为了实现上述目的,本发明提供如下技术方案:
本发明的一种海豹油应用于心律不齐、肝气不通的保健饼干,它是由下述重量份的原料配制而成的:海豹油2~5份、大枣2~5份、黄芩2~5份、核桃仁2~5份、茴香1~3份、金毛狗脊2~6份、菟丝子2~5份、阿胶2~6份、蜂蜜5~10份、高粱面50~100份。
作为本发明进一步的方案:它是由下述重量份的原料配制而成的:海豹油5份、大枣5份、黄芩5份、核桃仁5份、茴香3份、金毛狗脊6份、菟丝子5份、阿胶6份、蜂蜜8份、高粱面100份。
本发明还提供上述一种海豹油应用于心律不齐、肝气不通的保健饼干的制备方法,本技术领域中通常人们采用熟知的方法包括如下步骤:
1)称取下述药食两用重量份原料:海豹油2~5份、大枣2~5份、黄芩2~5份、核桃仁2~5份、茴香1~3份、金毛狗脊2~6份、菟丝子2~5份、阿胶2~6份、蜂蜜5~10份、高粱面50~100份;
2)将上述黄芩、茴香、金毛狗脊、菟丝子一起加水煎煮二次,第一次加水8倍量,煎煮2小时,第二次加水6倍量,煎煮1小时,合并提取液,滤过,滤液浓缩至相对密度为1.15~1.20,加乙醇至含醇量为70%,搅拌均匀,冷藏静置,滤过,滤液减压回收乙醇至无醇味并浓缩至稠膏;
3)取大枣、核桃仁、阿胶用水煎煮三次,每次用水量为原料重量的8-10倍量,煎煮三次,每次l-2小时,滤过,滤液浓缩合并浓缩至浸膏加入蜂蜜搅拌均匀,冷却,打粉备用;
4)面团调制:将步骤2)和步骤3)分别得到的稠膏和浸膏加入到100公斤高粱面和24~26公斤和面水中混溶,要严格控制面团的温度在22-28℃,搅拌时间在6-12min,再掺入标准用量的增香剂、盐、膨松剂、海豹油,边搅拌边混合均匀制成饼干面丕,备用;
5)滚扎:将上述面丕以3-8次单向往复滚扎,面片厚度约为2~3厘米;
6)成型:将步骤5)经滚扎工序扎成的面片,经各种型号的成型机制成各种形状的饼干;
7)烘烤:将步骤6)制成的饼干放入烘烤箱中,烘烤温度控制在240-260℃,焙烤时间5-8min,在高温的作用下,饼干内部的水分蒸发,淀粉受热糊化,膨松剂分解而使饼干体积增大,面筋蛋白质受热变质而凝固,形成多孔酥松的饼干成品;
8)冷却、包装:将上述得到的饼干成品从烤箱内取出,需凉透之后再进行计量、包装、出厂。
本发明所采用的原料具有如下特性:
海豹油:长期以来,世界医学界就发现生活在加拿大纽芬兰省的爱斯基摩人很少患心脑血管、高血压、癌症等疾病。到了70年代,加拿大的一些医学博士经研究得出结论,爱斯基摩人的饮食主要是海豹肉、海豹油及鱼类等,由于这些食物中含有丰富的OMEGA-3,所以才未导致他们患上现代人的这些“文明病”。随着人们对OMEGA-3的研究开始逐步深入,超过1.5万份研究报告指出,OMEGA-3具有抗炎症、抗血栓形成、抗心律失常、降低血脂、舒张血管等功能。海豹油是从海豹脂肪组织提取的一种富含 OMEGA-3 不饱和脂肪酸的珍贵营养滋补品。海豹油中含有大约20%~25% 的OMEGA-3 不饱和脂肪酸,其含量为自然界中动物之最。同时,在海豹油中含有一定量的角鲨烯和维生素E。海豹油是从海豹脂肪组织提取的一 种富含 OMEGA-3 不饱和脂肪酸的珍贵营养滋补品。海豹油中含有大约20%~25% 的OMEGA-3不饱和脂肪酸,其含量为自然界中动物之最。同时,在海豹油中含有一定量的角鲨烯和维生素E。脂溶性活性物质 : 对于提高人体自身免疫力和调节胰岛素分泌有特殊效果。可预防和治疗类风湿性关节炎、红斑狼疮等。对糖尿病的形成也有抑制作用。EPA(二十碳五烯酸) :俗称“血管清道夫”,具有防止血管硬化和心脏血管栓塞、降低高血压及胆固醇等作用。用于冠状动脉硬化、脑中风、脑溢血、脑血管障碍、手脚麻痹、心悸等心脑血管疾病。DHA(二十二碳六烯酸) : 俗称“脑黄金”,是脑组织和视神经发育及功能发挥所必须的物质,可促进婴幼儿智力开发和智商提高,增强记忆力,预防和治疗老年痴呆症。DPA(二十二碳五烯酸) :在人乳和海豹油中含量高,是鱼油及其它食品所缺乏的。它可促进和提高人体的免疫力,对糖尿病、类风湿性关节炎、牛皮癣、大小肠炎等有治疗作用。QUALENE(角鲨烯) : 天然抗氧化剂,有防癌和抗癌及美容作用,可有效保持皮肤的滋润光滑及弹性。脂溶性活性物质 :对于提高人体自身免疫力和调节胰岛素分泌有特殊效果。可预防和治疗类风湿性关节炎、红斑狼疮等。对糖尿病的形成也有抑制作用。
大枣:红枣,又名大枣。特点是维生素含量非常高,有“天然维生素丸”的美誉,具有滋阴补阳,补血之功效。大枣含有大量的糖类物质,主要为葡萄糖,还含有果糖、蔗糖及由葡萄糖和果糖组成的低聚糖、阿拉伯聚糖及半乳醛聚糖等;并含有大量的维生素C、核黄素、硫胺素、胡萝卜素、尼克酸等多种维生素。具有较强的补养作用,能提高人体免疫功能,增强抗病能力。红枣具有补虚益气、养血安神、健脾和胃等功效,是脾胃虚弱、气血不足、倦怠无力、失眠等患者良好的保健营养品。
黄芩:黄芩的根入药,味苦、性寒,有清热燥湿、泻火解毒、止血等功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、高血压、痈肿疖疮等症。黄芩的临床抗菌性比黄连好,而且不产生抗药性。性味:苦,寒。功能主治:泻实火,除湿热,止血,安胎。治壮热烦渴,肺热咳嗽,湿热泻痢,黄疸,热淋,吐、衄、崩、漏,目赤肿痛,胎动不安,痈肿疔疮。
核桃仁:核桃仁为胡桃核内的果肉,又名胡桃仁、胡桃肉。核桃为胡桃科、胡桃属植物,乔木,高达20~25米;树干较别的种类矮,树冠广阔;树皮幼时灰绿色,老时则灰白色而纵向浅裂;小枝无毛,具光泽,被盾状着生的腺体,灰绿色,后来带褐色。1、补虚强体,提供营养:经动物实验证明,含胡桃油的混合脂肪饮食,可使体重增长,血清白蛋白增加,而血胆固醇水平升高却较慢,故核桃是难得的一种高脂肪性物质的补养品。
2、消炎杀菌,养护皮肤:桃核仁有直接的抑菌消炎作用。据临床报道,将核桃仁捣烂制成的核桃焦油氧化锌糊膏,治疗皮炎、湿疹,有效率可达100%。核桃仁富含的油脂,有利于润泽肌肤,保持人体活力。
3、防癌抗癌:实验证明,核桃有效成分对小鼠S37肿瘤有抑制作用。核桃技对多种肿瘤,如食道癌、胃癌、鼻咽癌、肺癌、甲状腺癌、淋巴肉瘤等都有一定的抑制作用。此外,核桃对癌症患者还有镇痛,提升白细胞及保护肝脏等作用。
4、健脑防老:核桃仁含有较多的蛋白质及人体营养必需的不饱和脂肪酸,这些成分皆为大脑组织细胞代谢的重要物质,能滋养脑细胞,增强脑功能。
5、净化血液,降低胆固醇:核桃仁能减少肠道对胆固醇的吸收。并可溶解胆固醇,排除血管壁内的“污垢杂质”使血液净化,从而为人体提供更好的新鲜血液。所以,核桃仁有防止动脉硬化,降低胆固醇的作用。此外,核桃还可用于治疗非胰岛素依赖型糖尿病。
6、 核桃仁中含有较多的蛋白质和人体必需的不饱和脂肪酸,这些成分有非常好的补脑效果,能滋养脑细胞,增强脑功能。
7、 核桃仁可有效防止动脉硬化,降低胆固醇的作用;此外,核桃还可用于治疗非胰岛素依赖型糖尿病;同时,可提升白细胞,保护肝脏。
8、 核桃仁含有大量维生素E,经常食用有润肺、黑发的作用。
9、 舒缓疲劳、抗压。
10、 润燥滑肠:用于用于肠燥便秘的大便难解,同时有较强的活血调经、祛瘀生新的功效,对止咳也有一定疗效。
茴香:茴香菜又原名小怀香,又称香丝菜、小茴香、茴香子、谷香(四川、贵州)丶浑香,嫩叶作菜蔬,是小茴香的茎部,为伞形科植物茴香的干燥成熟果实。茴香菜含有丰富的维生素B1、B2、C、PP、胡萝卜素以及纤维素,导致它具有特殊的香辛气味的是茴香油,可以刺激肠胃的神经血管,具有健胃理气的功效,所以它是搭配肉食和油脂的绝佳蔬菜。
茴香菜熟食或泡酒饮服,可行气、散寒、止痛。茴香苗叶生捣取汁饮或外敷,可治恶毒痈肿。茴香味辛,性温。开胃进食,理气散寒,有助阳道。
金毛狗脊:金毛狗脊为蚌壳蕨科植物金毛狗的根茎。金毛狗脊根茎含淀粉30%左右。狗脊蕨根茎含淀粉高达48.5%,并含鞣质类。根茎含淀粉及绵马酚;根茎的柔毛含鞣质及色素。【性味】苦、甘,温。【归经】归肝、肾经。【功能主治】补肝肾,强腰脊,祛风湿。用于腰膝酸软,下肢无力,风湿痹痛。金毛狗植株上金黄色的茸毛,是良好的止血药。狗脊属强壮筋骨药,对筋骨不健的病证有治疗和保健的双重作用。主治腰脊强痛,不能俯仰,足膝软弱及风湿腰痛等症。有温补固摄作用,治疗尿频、遗尿,造精,带下等。
菟丝子:菟丝子(学名:Cuscuta chinensis Lam.),别名禅真、豆寄生、豆阎王、黄丝、黄丝藤、鸡血藤、金丝藤等。一年生寄生草本。茎缠绕,黄色,纤细,无叶。菟丝子是一味平补肾、肝、脾之良药,临床主要应用于肾虚腰痛、阳痿遗精、尿频、宫冷不孕、目暗便溏之肾阴阳虚证。菟丝子甘、温,归肾、肝、脾经,具有滋补肝肾、固精缩尿、安胎、明目、止泻之功效,始载《神农本草经》,被列为上品。甘味一般具有滋补作用,甘辛微温,禀气中和,既可补阳,又可益阴,具有温而不燥,补而不滞的特点。固精安胎与性激素样作用。中医认为肾为先天之本,内寓元阴与元阳,是人体生殖发育的根源,脏腑机能活动的原动力。
阿胶:【别名】驴皮胶【来源】本品为马科动物驴Equus Asinus L.的皮经煎煮、浓缩制成的固体胶。【性味】甘,平。【归经】归肺、肝、肾经。【功能主治】补血滋阴,润燥,止血。用于血虚萎黄,眩晕心悸,肌痿无力,心烦不眠,虚风内动,肺燥咳嗽,劳嗽咯血,吐血尿血,便血崩漏,妊娠胎漏。【性味】甘,平。【归经】归肺、肝、肾经。
【功能主治】补血滋阴,润燥,止血。用于血虚萎黄,眩晕心悸,肌痿无力,心烦不眠,虚风内动,肺燥咳嗽,劳嗽咯血,吐血尿血,便血崩漏,妊娠胎漏。③防治进行性肌营养障碍症的作用。
蜂蜜:【别名】:石蜜、石饴、食蜜、蜜、白蜜、白沙蜜、蜜糖、沙蜜、蜂糖、【药材类别】:【性味】:味甘;性平。 【归经】:入肺、牌、大肠经。 调补脾胃;缓急止痛;润肺止咳;润肠通便;润肤生肌;解毒。主脘腹虚痛;肺燥咳嗽;肠燥便秘;目赤;口疮;溃疡不敛;风疹瘙痒;水火烫伤;手足(军皮)裂。用于脘腹虚痛,肺燥干咳,肠燥便秘;外治疮疡不敛,水火烫伤。
高粱面:有天然营养食品的美誉,它含淀粉65.9%—77.4%,蛋白质8.4%—14.5%,粗脂2.4%—10.4%,是人们喜爱的食品之一。经常食用高粱面,对人体健康有益,特别是患有高血压,高血脂,糖尿病等的人往常食用高粱面能起到一定辅助医疗的作用。中医认为,高粱具有温中健脾、固肠胃、止吐泻的作用。1.高粱的主要功效是补气、健脾、养胃、止泻,特别适用于小孩消化不良,脾胃气虚,大便稀溏等不良症状,患有慢性腹泻的病人常食高粱米粥有明显疗效。
有益效果
与现有技术的相比,本发明的有益效果是:本发明的一种海豹油应用于心律不齐、肝气不通的保健饼干的优点在于:
(1)提供了EPA(二十碳五烯酸):俗称“血管清道夫”,具有防止血管硬化和心脏血管栓塞、降低高血压及胆固醇等作用。用于冠状动脉硬化、脑中风、脑溢血、脑血管障碍、手脚麻痹、心悸等心脑血管疾病科学配伍海豹油、大枣、黄芩、核桃仁、茴香、金毛狗脊、菟丝子、阿胶、蜂蜜、高粱面制成的营养饼干,增加了食品治疗新领域,满足了患者可以多种选择方向。
(2)本发明的海豹油应用于心律不齐、肝气不通的保健饼干特别对针对人体新陈代谢异常预防保健,达到体内电解质平衡,肝气不顺的症状,缺血性心脏病(冠状动脉疾病),风湿性心脏病,心肌炎,心肌病变等症状具有快速调理作用,临床验证表明本发明的海豹油应用于心律不齐、肝气不通的保健饼干效果显著,本发明的海豹油应用于心律不齐、肝气不通的保健饼干所达疗效是本领域普通技术人员意想不到的。
(3)本发明的海豹油应用于心律不齐、肝气不通的保健饼干制备工艺简单、制成饼干方便咀嚼食用、易消化、易吸收等特点,其生产工艺简单,成本低,具有广大经济效益和社会效益。
具体实施方式
下面将结合本发明实施例中,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
实施例1
原料:海豹油5份、大枣5份、黄芩5份、核桃仁5份、茴香3份、金毛狗脊6份、菟丝子5份、阿胶6份、蜂蜜8份、高粱面100份。
制备:
1)称取下述药食两用重量份原料:海豹油5份、大枣5份、黄芩5份、核桃仁5份、茴香3份、金毛狗脊6份、菟丝子5份、阿胶6份、蜂蜜8份、高粱面100份;
2)将上述黄芩、茴香、金毛狗脊、菟丝子一起加水煎煮二次,第一次加水8倍量,煎煮2小时,第二次加水6倍量,煎煮1小时,合并提取液,滤过,滤液浓缩至相对密度为1.15~1.20,加乙醇至含醇量为70%,搅拌均匀,冷藏静置,滤过,滤液减压回收乙醇至无醇味并浓缩至稠膏;
3)取大枣、核桃仁、阿胶用水煎煮三次,每次用水量为原料重量的8-10倍量,煎煮三次,每次l-2小时,滤过,滤液浓缩合并浓缩至浸膏加入蜂蜜搅拌均匀,冷却,打粉备用;
4)面团调制:将步骤2)和步骤3)分别得到的稠膏和浸膏加入到100公斤高粱面和24~26公斤和面水中混溶,要严格控制面团的温度在22-28℃,搅拌时间在6-12min,再掺入标准用量的增香剂、盐、膨松剂、海豹油,边搅拌边混合均匀制成饼干面丕,备用;
5)滚扎:将上述面丕以3-8次单向往复滚扎,面片厚度约为2~3厘米;
6)成型:将步骤5)经滚扎工序扎成的面片,经各种型号的成型机制成各种形状的饼干;
7)烘烤:将步骤6)制成的饼干放入烘烤箱中,烘烤温度控制在240-260℃,焙烤时间5-8min,在高温的作用下,饼干内部的水分蒸发,淀粉受热糊化,膨松剂分解而使饼干体积增大,面筋蛋白质受热变质而凝固,形成多孔酥松的饼干成品;
8)冷却、包装:将上述得到的饼干成品从烤箱内取出,需凉透之后再进行计量、包装、出厂。
实施例2
原料:海豹油4份、大枣2份、黄芩2份、核桃仁2份、茴香1份、金毛狗脊2份、菟丝子2份、阿胶2份、蜂蜜5份、高粱面50份。
制备方法同实施例1相同。
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效结构或等效流程变换,或直接或间接运用在其它相关的技术领域,均同理包括在本发明的专利保护范围内。
典型病例
病例1 马先生,男,45岁。患病特征:T36.5℃P60次/分R18次/分BP140/80mmHg神志清,精神不振,发育正常,营养中等,自主体位,查体合作。全身皮肤黏膜无黄染及出血点,浅表淋巴结未触及肿大,头颅正无畸形,双瞳孔等大等圆,对光反射灵敏。口唇无紫绀,伸舌居中,咽无充血,扁桃体不大。颈静脉无充盈,无异常搏动,未闻及血管杂音,胸廓对称无畸形,双肺呼吸音清,未闻及干湿罗音,心率60次/分,心音低钝,律齐,无杂音。腹平软,无压痛及反跳痛,肝脾肋下未触及,双下肢无浮肿。生理反射存在,病理反射未引出。之后得知有本发明的保健饼干可以预防和治疗心律不齐、肝气不通的,果断选择服用,每天早餐就吃本发明的保健饼干,坚持吃了1个星期,发现自己内电解质平衡好多了,心跳频率较正常,之后连续吃了1个月医院心电图检查,无异常,完全康复。
病例2 林先生,男50。【主诉】 发作性心慌3月 【现病史】 3个月前因饮酒后发作心慌,无胸痛、胸闷气短,无头痛、头晕黑盟晕厥等。每次发作可持续20分钟自动缓解,无突发突止,反复发作。发病后,一般情况可。 【查体】 体征:血压130/90mmhg,神情,精神好,双肺呼吸音清,心率80BPM,律齐,无杂音。 检查:心电图检查:窦.性心律2.偶发室性早搏.动态心电。之后林先生一直买本发明的保健饼干吃,现在心律不齐症晚上治愈,至今未见复发。
病例3 胡女士,60岁,2015年底颜面腿部浮肿,查出尿蛋白是800+mg/24h,比正常人高出十多倍。立即寻医求药,凭医保卡到省级医院住院数次,尿蛋白指标一直没有任何变动,诊为肝气不通,服中药三个月,浮肿消除,尿蛋白降至120~130mg/24h。之后她开始吃本发明的保健饼干吃了半年后回访,情况稳定,脸色红润,精神佳有活力。
Claims (3)
1.一种海豹油应用于心律不齐、肝气不通的保健饼干,其特征在于,它是由下述重量份的原料配制而成的:海豹油2~5份、大枣2~5份、黄芩2~5份、核桃仁2~5份、茴香1~3份、金毛狗脊2~6份、菟丝子2~5份、阿胶2~6份、蜂蜜5~10份、高粱面50~100份。
2.根据权利要求1所述的一种海豹油应用于心律不齐、肝气不通的保健饼干,其特征在于,它是由下述重量份的原料配制而成的:海豹油5份、大枣5份、黄芩5份、核桃仁5份、茴香3份、金毛狗脊6份、菟丝子5份、阿胶6份、蜂蜜8份、高粱面100份。
3.根据权利要求1所述的一种海豹油应用于心律不齐、肝气不通的保健饼干的制备方法,其特征在于该方法包括如下步骤:
1)称取下述药食两用重量份原料:海豹油2~5份、大枣2~5份、黄芩2~5份、核桃仁2~5份、茴香1~3份、金毛狗脊2~6份、菟丝子2~5份、阿胶2~6份、蜂蜜5~10份、高粱面50~100份;
2)将上述黄芩、茴香、金毛狗脊、菟丝子一起加水煎煮二次,第一次加水8倍量,煎煮2小时,第二次加水6倍量,煎煮1小时,合并提取液,滤过,滤液浓缩至相对密度为1.15~1.20,加乙醇至含醇量为70%,搅拌均匀,冷藏静置,滤过,滤液减压回收乙醇至无醇味并浓缩至稠膏;
3)取大枣、核桃仁、阿胶用水煎煮三次,每次用水量为原料重量的8-10倍量,煎煮三次,每次l-2小时,滤过,滤液浓缩合并浓缩至浸膏加入蜂蜜搅拌均匀,冷却,打粉备用;
4)面团调制:将步骤2)和步骤3)分别得到的稠膏和浸膏加入到100公斤高粱面和24~26公斤和面水中混溶,要严格控制面团的温度在22-28℃,搅拌时间在6-12min,再掺入标准用量的增香剂、盐、膨松剂、海豹油,边搅拌边混合均匀制成饼干面丕,备用;
5)滚扎:将上述面丕以3-8次单向往复滚扎,面片厚度约为2~3厘米;
6)成型:将步骤5)经滚扎工序扎成的面片,经各种型号的成型机制成各种形状的饼干;
7)烘烤:将步骤6)制成的饼干放入烘烤箱中,烘烤温度控制在240-260℃,焙烤时间5-8min,在高温的作用下,饼干内部的水分蒸发,淀粉受热糊化,膨松剂分解而使饼干体积增大,面筋蛋白质受热变质而凝固,形成多孔酥松的饼干成品;
8)冷却、包装:将上述得到的饼干成品从烤箱内取出,需凉透之后再进行计量、包装、出厂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610691589.3A CN106138832A (zh) | 2016-08-21 | 2016-08-21 | 一种海豹油应用于心律不齐、肝气不通的保健饼干 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610691589.3A CN106138832A (zh) | 2016-08-21 | 2016-08-21 | 一种海豹油应用于心律不齐、肝气不通的保健饼干 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106138832A true CN106138832A (zh) | 2016-11-23 |
Family
ID=57330380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610691589.3A Withdrawn CN106138832A (zh) | 2016-08-21 | 2016-08-21 | 一种海豹油应用于心律不齐、肝气不通的保健饼干 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106138832A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435186A (zh) * | 2003-03-11 | 2003-08-13 | 刘威 | 精制海狗油在制备防治老年痴呆及中风后遗症药中的应用 |
CN1781384A (zh) * | 2004-12-01 | 2006-06-07 | 山东东阿阿胶股份有限公司 | 阿胶膏及其制备方法 |
CN101194913A (zh) * | 2006-12-05 | 2008-06-11 | 张金生 | 治疗血脂偏高的天然海豹油浓缩生物制剂及其制备工艺 |
CN104839292A (zh) * | 2015-05-14 | 2015-08-19 | 奚济孝 | 一种胃寒疼痛的营养保健饼干及制备方法 |
-
2016
- 2016-08-21 CN CN201610691589.3A patent/CN106138832A/zh not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435186A (zh) * | 2003-03-11 | 2003-08-13 | 刘威 | 精制海狗油在制备防治老年痴呆及中风后遗症药中的应用 |
CN1781384A (zh) * | 2004-12-01 | 2006-06-07 | 山东东阿阿胶股份有限公司 | 阿胶膏及其制备方法 |
CN101194913A (zh) * | 2006-12-05 | 2008-06-11 | 张金生 | 治疗血脂偏高的天然海豹油浓缩生物制剂及其制备工艺 |
CN104839292A (zh) * | 2015-05-14 | 2015-08-19 | 奚济孝 | 一种胃寒疼痛的营养保健饼干及制备方法 |
Non-Patent Citations (3)
Title |
---|
《直销与中国》编写组: "《直销与中国》", 28 February 2005, 人民日报出版社 * |
成向东: "《打通你的任督二脉》", 30 April 2014, 吉林科学技术出版社 * |
胡郁坤等: "《袖珍中药应用速查手册(插图本)》", 30 April 2012, 湖南科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102511869B (zh) | 红枣生姜浓浆 | |
CN106399030A (zh) | 一种保健荔枝甜酒及其制备方法 | |
CN103602551B (zh) | 一种有助于消食健胃复方中草药发酵保健酒及其生产方法 | |
CN103637205A (zh) | 一种石菖蒲补脑健脑汤料的配方及生产方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN107338150A (zh) | 一种沉香保健酒曲及其制备方法 | |
CN107596197A (zh) | 一种补气解郁茶及其制备方法 | |
CN103830558B (zh) | 一种抗衰老组合物及其制备方法 | |
CN105558977A (zh) | 一种制备具有壮阳散寒功效的固体羊肉汤的方法 | |
KR20130065375A (ko) | 한방 빵 제조방법 | |
CN108295212A (zh) | 一种药食两用酒及其制备方法 | |
CN103734609B (zh) | 增强心脑供血,供氧,健脾补气,养血补肾药食同膳面 | |
CN106106638A (zh) | 一种护肝面包及其制作方法 | |
CN103272147B (zh) | 一种治疗妊娠呕吐的中药制剂 | |
CN105998639A (zh) | 一种降脂降压饮液及其制备方法 | |
CN106072290A (zh) | 一种可减少孕吐又可补充营养的羹汤及制备方法 | |
CN106074765A (zh) | 一种安神、助睡眠的中药组合物 | |
CN105851857A (zh) | 适用于中老年的面条及其加工方法 | |
CN106138832A (zh) | 一种海豹油应用于心律不齐、肝气不通的保健饼干 | |
CN104524358A (zh) | 一种辅助治疗缺铁性贫血的药丸及制备方法 | |
CN104799276B (zh) | 一种麻七利血溶栓粉及其制备方法 | |
CN103039574A (zh) | 一种缓解气血亏虚的保健糕饼及其制备方法 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 | |
CN106343092A (zh) | 一种养肝益精茶凉茶饮料及其制备方法 | |
CN109222084A (zh) | 一种清热败火添加剂及其在制备面包中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161123 |